Manulife Extends Strategic Partnership with CUHK Medical Centre to Include Histotripsy in its Holistic"Medical Professional Support Service"

Histotripsy is an FDA-approved technology that offers liver cancer patients a non-invasive, painless, and highly effective treatment option

HONG KONG,March 7, 2025/PRNewswire/ -- Manulife announced today the extension of its strategic partnership with CUHK Medical Centre (CUHKMC), originally established in 2021, as part of its commitment to enhancing access to quality healthcare for its customers. Manulife is pleased to share that, through its Holistic"Medical Professional Support Service" for specified medical insurance plan[1]customers diagnosed with cancer or suspected of having cancer, it will incorporate histotripsy as a treatment option, once this treatment becomes publicly available at CUHKMC, and patients would be enrolled in clinical trials for close monitoring and evaluation of the clinical outcome.

Liver cancer is the fifth most common cancer inHong Kong, making up 4.6% of all new cancer cases in 2022.[2]Histotripsy is an FDA-approved technology that offers liver cancer patients a non-invasive, painless, and highly effective treatment option.[3]Earlier, this treatment was introduced to medical institutions inHong Kongthrough donations from the Li Ka Shing Foundation.[3]

"This extended partnership highlights Manulife's commitment to being a pioneering health insurance provider inHong Kong, supporting our customers throughout their health journeys and helping to protect more lives,"saidCarrie Tong, Chief Operations Officer of Manulife Hong Kong andMacau.

All Manulife medical plan customers are eligible for coverage of this innovative and FDA-approved histotripsy treatment, further underscoring Manulife's dedication to enhancing the quality of healthcare accessible to customers.

Manulife established a strategic partnership with CUHKMC in 2021, providing eligible customers with priority access to the hospital's oncologists for a one-time, free independent medical consultation. In 2023, this partnership was expanded to offer a cashless pre-approval service for over 300 all-inclusive hospital packages, including endoscopic and surgical procedures provided by CUHKMC.

Manulife has extended its strategic partnership with CUHK Medical Centre to incorporate histotripsy into its holistic “Medical Professional Support Service”.

About Manulife Hong Kong 

Manulife Hong Kong has been a trusted name for more than 125 years. Since our operations started inAsiain 1897, we have grown to become one of the top-tier providers of financial services, offering a diverse range of protection and wealth products and services to over 2.6 million customers inHong KongandMacau. We are committed to helping make decisions easier and lives better for our customers.

Manulife Hong Kong, through Manulife International Holdings Limited, owns Manulife (International) Limited, Manulife Investment Management (Hong Kong) Limited, and Manulife Provident Funds Trust Company Limited. These entities are all subsidiaries of Manulife Financial Corporation.

About Manulife 

Manulife Financial Corporation is a leading international financial services provider, helping our customers make their decisions easier and lives better. With our global headquarters inToronto, Canada, we operate as Manulife acrossCanada,Asia, andEurope, and primarily asJohn Hancockinthe United States, providing financial advice and insurance for individuals, groups and businesses. Through Manulife Wealth& Asset Management, we offer global investment, financial advice, and retirement plan services to individuals, institutions, and retirement plan members worldwide. At the end of 2024, we had more than 37,000 employees, over 109,000 agents, and thousands of distribution partners, serving over 36 million customers. We trade as'MFC'on theToronto,New York, and the Philippine stock exchanges, and under'945'inHong Kong.

Not all offerings are available in all jurisdictions. For additional information, please visitmanulife.com.

[1] Terms and conditions apply. Eligibility to Holistic"Medical Professional Support Service"applies to customers of Manulife Supreme VHIS Flexi Plan, Manulife Supreme Lite VHIS Supplementary Benefit, Manulife Supreme Medical Plan, Manulife Supreme Lite Medical Supplementary Benefit, ManuMaster Healthcare Series/Benefit, and ManuShine Healthcare Series/Benefit. The content of this press release does not contain all the terms and conditions of policies, and the full terms and conditions are set out in the policy documents. ManuMaster Healthcare Series/Benefit and ManuShine Healthcare Series/Benefit are available as basic plans or supplementary benefits. 

[2] Figures from the Centre for Health Protection under the HKSAR Department of Health.

[3] "Li Ka Shing Foundation funds non-invasive liver cancer treatment for Hong Kong patients"(SCMP, Aug 27, 2024)

 

CisionView original content to download multimedia:https://www.prnewswire.com/apac/news-releases/manulife-extends-strategic-partnership-with-cuhk-medical-centre-to-include-histotripsy-in-its-holistic-medical-professional-support-service-302395495.html

SOURCE Manulife Hong Kong